Adjuvant Capital is a venture capital firm that prefers to invest in businesses in the life science sector. Founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz in New York, New York. The firm invests in Early Stage Venture. The notable investment portfolio of the Adjuvant Capital includes AN2 Therapeutics, Themis, InDevR, and X-Vax.
As of December 2019, Sony Innovation Fund has made 4 investments and actively looking for new investment opportunities. Adjuvant Capital typically invests around $10-$25 million.
Timeline
People
Charlie Petty
Principal
Christian Mandl
SENIOR ADVISOR / BOSTON
Curt LaBelle
VENTURE PARTNER / NEW YORK
Evelyn Yanatos
FINANCE DIRECTOR / NEW YORK
Gerard Cunningham
OPERATING PARTNER
Glenn Rockman
FOUNDER / MANAGING PARTNER / NEW YORK
Jenny Yip
MANAGING PARTNER / SAN FRANCISCO
Jim Robinson
SENIOR ADVISOR
Kabeer Aziz
PRINCIPAL / NEW YORK
Kim Kamdar
PARTNER / SAN DIEGO
Lilly deSouza Burr
ASSOCIATE / NEW YORK
Mark Sullivan
VENTURE PARTNER
Michael Chang
PRINCIPAL / NEW YORK
Peter Patriarca
SENIOR ADVISOR / DC
Further reading
Documentaries, videos and podcasts
Companies
AN2 Therapeutics
InDevR
Themis Bioscience
X-Vax Technology
News
References
Company attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 3
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 4
Aime Anne Nisay
QA Engineer of web and mobile applications - 5
Carla Faraguna
Golden People and Operations. - 6
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME